Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genetic SignaturesASX:GSS -1.49% Current Ratio is 8.99 as of Dec. 2025, which is 14% below its 10-year median of 10.48. The stock has 4 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Genetic Signatures ranks better than 93.43% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Genetic Signatures's current ratio for the quarter that ended in Dec. 2025 was 8.99.
Genetic Signatures has a current ratio of 8.99. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Genetic Signatures's Current Ratio or its related term are showing as below:
ASX:GSS'
s Current Ratio Range Over the Past 10 Years
Min: 3.37 Med: 10.48 Max: 25.08
Current: 8.99
During the past 11 years, Genetic Signatures's highest Current Ratio was 25.08. The lowest was 3.37. And the median was 10.48.
ASX:GSS's Current Ratio is ranked better than 93.43% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.1
vs ASX:GSS: 8.99
Genetic Signatures (ASX:GSS) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Genetic Signatures Current Ratio Related Terms
Genetic Signatures Current Ratio Historical Data
* Premium members only.
The historical data trend for Genetic Signatures's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:GSS vs TMO, DHR, IDXX: Current Ratio Comparison
For the Diagnostics & Research subindustry, Genetic Signatures's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetic Signatures Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Current Ratio distribution charts can be found below:
* The bar in red indicates where Genetic Signatures's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetic Signatures (ASX:GSS) has a Current Ratio of 8.99 as of Dec. 2025. This is 14% below median its historical median of 10.48. Over the past decade, Genetic Signatures' Current Ratio has ranged from 3.37 to 25.08. According to the industry distribution chart, Genetic Signatures ranks #14 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 6.6%.
Is Genetic Signatures' Current Ratio too high?
Genetic Signatures' current Current Ratio of 8.99 is 14% below median its 10-year median of 10.48. Over the past 10 years, this metric has ranged from a low of 3.37 to a high of 25.08. The Medical Diagnostics & Research industry median Current Ratio is 2.10. Genetic Signatures' value of 8.99 is 328.1% above this industry median. Based on the distribution chart, Genetic Signatures ranks #14 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Genetic Signatures' Current Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Genetic Signatures ranks #14 out of 213 companies for Current Ratio. This places Genetic Signatures in the top 7% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.10. Genetic Signatures' value of 8.99 is 328.1% above this benchmark. Historically, Genetic Signatures' own Current Ratio has ranged from 3.37 to 25.08 over the past decade. While the company's 10-year median is 10.48 vs. the industry median of 2.10, Genetic Signatures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 2.10, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genetic Signatures's current Current Ratio of 8.99 is 328.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetic Signatures's current Current Ratio is 8.99, which is 14% below median its own 10-year median of 10.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Signatures stock overvalued right now?
Based on GuruFocus' analysis, Genetic Signatures (ASX:GSS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.38, compared to a current price of A$0.07 — trading 82.6% below its estimated fair value. The current Current Ratio is 8.99, which is 14% below median its 10-year median of 10.48 and 328.1% above the Medical Diagnostics & Research industry median of 2.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Genetic Signatures (ASX:GSS), the current Current Ratio is 8.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genetic Signatures Ltd is a specialist molecular diagnostics company, specializing in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are based in Australia, with sales and support teams in the UK, Germany, and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:GSS has been successfully added to your 
